Pityriasis Rubra Pilaris refractory to ustekinumab successfully treated with guselkumab
Abstract Pityriasis Rubra Pilaris (PRP) is a rare papulosquamous inflammatory dermatosis with variable clinical presentation and poorly understood pathogenesis that often poses diagnostic and therapeutic challenges. Data on currently available treatment options are limited, particularly when facing...
Saved in:
Main Authors: | João Teixeira (Author), Ana L. Matos (Author), André Aparício‐Martins (Author), Joana Calvão (Author), Hugo S. deOliveira (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Refractory pityriasis rubra pilaris treated with upadacitinib
by: Eingun James Song, MD, et al.
Published: (2023) -
Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab
by: Bárbara Vieira Granja, et al.
Published: (2024) -
Ustekinumab as an Alternative Treatment Option for Chronic Pityriasis Rubra Pilaris
by: Mudit Chowdhary, et al.
Published: (2015) -
Successful treatment of juvenile pityriasis rubra pilaris with ustekinumab in a 7-year-old girl
by: Lauren Bonomo, BA, et al.
Published: (2018) -
Management of refractory pityriasis rubra pilaris: challenges and solutions
by: Moretta G, et al.
Published: (2017)